Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Gastric Cancer
Multicentre, Phase II Study With Cabazitaxel in Previously Treated Patients With Advanced or Metastatic Adenocarcinoma of the Oesophagogastric Junction and Stomach
Sponsor: Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Listed as NCT01956149, this PHASE2 trial focuses on Gastric Cancer and remains completed. Sponsored by Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest, it has been updated 8 times since 2013, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
8 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE2
-
Jan 2021 — Jul 2024 [monthly]
Completed PHASE2
-
May 2020 — Jan 2021 [monthly]
Completed PHASE2
-
Jun 2018 — May 2020 [monthly]
Completed PHASE2
▶ Show 3 earlier versions
-
May 2018 — Jun 2018 [monthly]
Completed PHASE2
Status: Active Not Recruiting → Completed
-
Jan 2018 — May 2018 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Jan 2018 [monthly]
Active Not Recruiting PHASE2
First recorded
Sep 2013
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
For direct contact, visit the study record on ClinicalTrials.gov .